SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-20-013252
Filing Date
2020-11-09
Accepted
2020-11-09 07:49:58
Documents
59
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 10-Q morf-20200930x10q.htm 10-Q 1881511
2 EX-31.1 morf-20200930ex311eda00d.htm EX-31.1 13034
3 EX-31.2 morf-20200930ex31259e290.htm EX-31.2 13566
4 EX-32.1 morf-20200930ex3218ff42d.htm EX-32.1 6985
5 EX-32.2 morf-20200930ex322ee18fe.htm EX-32.2 6373
  Complete submission text file 0001558370-20-013252.txt   6281459

Data Files

Seq Description Document Type Size
6 EX-101.INS morf-20200930.xml EX-101.INS 1298688
7 EX-101.SCH morf-20200930.xsd EX-101.SCH 30329
8 EX-101.CAL morf-20200930_cal.xml EX-101.CAL 40955
9 EX-101.DEF morf-20200930_def.xml EX-101.DEF 205429
10 EX-101.LAB morf-20200930_lab.xml EX-101.LAB 352417
11 EX-101.PRE morf-20200930_pre.xml EX-101.PRE 300650
Mailing Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451
Business Address 35 GATEHOUSE DRIVE A2 WALTHAM MA 02451 9787296480
Morphic Holding, Inc. (Filer) CIK: 0001679363 (see all company filings)

IRS No.: 473878772 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38940 | Film No.: 201296140
SIC: 2834 Pharmaceutical Preparations